salvage of infected inbone total ankle replacement

12
Salvage of Infected INBONE Total Ankle Replacement Brent Roster, MD and George Lian, MD

Upload: vucong

Post on 13-Jan-2017

215 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Salvage of Infected INBONE Total Ankle Replacement

Salvage of Infected INBONE Total Ankle

Replacement

Brent Roster, MD and George Lian, MD

Page 2: Salvage of Infected INBONE Total Ankle Replacement

Salvage of Infected INBONE Total Ankle Replacement

Brent Roster, MD

My disclosure is in the Final AOFAS Mobile App.

I have no potential conflicts with this presentation.

Page 3: Salvage of Infected INBONE Total Ankle Replacement

Introduction

Reported rates of infection after total ankle replacement (TAR) requiring surgical I&D, component removal/exchange, or revision range from 0-8.6% 1-5,7,8

Traditional two-stage revision procedures can result in significant bone loss, making reconstruction difficult or impossible

The INBONE is a fixed-bearing TAR which utilizes a modular intramedullary tibial stem

Removal of a well-fixed INBONE tibial stem can be difficult and can result in significant morbidity

Page 4: Salvage of Infected INBONE Total Ankle Replacement

Biofilms and Periprosthetic Joint Infection

Bacterial biofilm formation on orthopaedic implants confers resistance to both host defense and antimicrobial agents 9

2-stage revision with removal of all components is therefore most commonly successful 5,9

Lombardi et al: 89% success with partial 2-stage revision of infected total hip arthroplasty (well-fixed femoral stems retained) at an average of 4 years 6

Kessler et al reported a 66.7% success rate at an average of 2 years in treatment of infected TAR with retention of one or both components 5

Page 5: Salvage of Infected INBONE Total Ankle Replacement

Methods Clinical question:

Can patients with an infected INBONE total ankle replacement AND a well-fixed tibial stem be successfully treated with partial 2-stage revision?

Can well-fixed tibial stem components be retained?

Study Design: Retrospective review of four consecutive patients with an infected INBONE total ankle replacement with at least 2 year follow-up after partial 2-stage revision

Page 6: Salvage of Infected INBONE Total Ankle Replacement

Methods

Well-fixed tibial stem components were left in-situ

All patients were treated with surgical I&D, removal of polyethylene, talar, and tibial tray components

Intra-operative cultures were obtained, and antibiotic management was guided by the infectious disease service

Antibiotic beads and antibiotic cement spacers were placed

TAR was re-implanted at an average of 3.75 months s/p explant and spacer placement after being off antibiotics for at least 6 weeks

Clinical exam, radiographs and inflammatory markers checked at most recent follow-up (average 26.5 months status post re-implantation)

Page 7: Salvage of Infected INBONE Total Ankle Replacement

Results: Demographics and Risk Factors

Patient Gender Age Initial Diagnosis Risk Factors for Infection

1 M 70 Primary OA DM; debridement and synovectomy for impingement after TAR

2 M 71 Post-traumatic OA None identified

3 M 49 Post-traumatic OA

Hepatitis C; history of open pilon fracture treated with ORIF and subsequent HWR

4 M 59 Post-traumatic OA

Prior foot surgery; debridement and synovectomy for impingement after TAR

OA = osteoarthritis; DM = diabetes mellitus; ORIF = open reduction internal fixation; HWR = hardware removal; TAR = total ankle replacement

Page 8: Salvage of Infected INBONE Total Ankle Replacement

Results: Infectious Characteristics

Pt Time to Explant (Months)

Pre-op labs Organism Antibiotic Duration of Abx therapy

Time to re-implantation (Months)

1 41 CRP 277 Alpha-hemolytic Strep

IV daptomycin

6 weeks 2

2 43 WBC 9.2, ESR 108

Propionibacterium PO rifampin & minocycline

1 year 4

3 39 CRP 0.8, ESR 31, WBC 8.1

Pseudomonas aeroginosa; GBS

cefepime 6 weeks 4

4 33 ESR 37, CRP 56.9, WBC 8.6

MSSA nafcillin 6 weeks 5

Avg = 39 Avg = 3.75

CRP = C reactive protein, mg/L, normal 0-9; WBC = white blood cell count, K/uL, normal = 4-11; ESR = erythrocyte sedimentation rate, mm/hr, normal 0-20; GBS = group B Streptococcus; MSSA = methicillin sensitive Staphylococcus aureus

Page 9: Salvage of Infected INBONE Total Ankle Replacement

Results: Most Recent Follow-up Pt F/u after re-

implantation (months)

ROM Narcotics? Clinical signs of infection at ankle?

Labs

1 34 35 no no WBC 5.8 ESR 17 CRP 0.5

2 24 22 no no WBC 6.0 ESR 31 CRP 5.5

3 24 25 no no WBC 7.3 ESR16 CRP 2.9

4 24 30 no no *** WBC 9.2 ESR 32 CRP 25.3

Avg = 26.5

*** At most recent f/u, Patient #4 had a pressure wound over the contralateral ankle and infected abdominal hernia mesh after bowel rupture during colonoscopy with resultant colostomy; operative ankle was benign with no signs of infection

Page 10: Salvage of Infected INBONE Total Ankle Replacement

Pre-op to Re-Implantation

Pre-op After I&D, poly and talar component removal and placement of antibiotic cement spacer

24 months after re-implantation

Page 11: Salvage of Infected INBONE Total Ankle Replacement

Discussion/Conclusion

4/4 patients treated with this approach had functional revision TARs at an average of 26.5 months follow-up

4/4 had no clinical signs of infection of their TAR

1/4 had elevated inflammatory markers at most recent follow-up, with an explanation other than their TAR

Conclusion: In this small series of 4 patients, all were successfully treated with partial 2-stage revision for infection with retention of the well-fixed INBONE tibial components with at least 2 years follow-up.

Page 12: Salvage of Infected INBONE Total Ankle Replacement

References

1. Adams SB, Demetracopoulos CA, Queen RA, Easley MF, DeOrio JK, Nunley JA. Early to mid-term results of fixed-bearing total ankle arthroplasty with a modular intramedullary tibial component. J Bone Jonit Surg Am. 2014;96:1983-9.

2. Daniels TR, Younger ASE, Penner M, Wing K, Dryden PJ, Wong H, Glazebrook M. Intermediate-term results of total ankle replacement and ankle arthrodesis. J Bone Joint Surg Am. 2014;96:135-42.

3. Gougoulias N, Khanna A, Maffulli N. How successful are current ankle replacements? Clin Orthop Relat Res. 2010;469:199-208.

4. Kessler B, Sendi P, Graber P, Knupp M, Zwickey L, Hintermann B, Zimmerli W. Risk factors for periprosthetic ankle joint infection: a case control study. J Bone Joint Surg Am. 2012;94:1871-6.

5. Kessler B, Knupp M, Graber P, Zwicky L, Hintermann B, Zimmerli W, Sendi P. The treatment and outcome of periprosthetic infection of the ankle. J Bone Joint Surg Br. 2014;96-B:772-7.

6. Lombardi AV, Berend KR, Adams JB. Partial two-stage exchange of the infected total hip replacement using disposable spacer moulds. J Bone Joint Surg Br. 2014;96-B(11 Supple A):66-9.

7. Myerson MS, Shariff R, Zonno AJ. The management of infection following total ankle replacement: demographics and treatment. Foot Ankle Int. 2014;35(9):855-862.

8. Sadoghi P, Roush G, Kastner N, Leithner A, Sommitsch C, Goswami T. Failure modes for total ankle arthroplasty: a statistical analysis of the Norwegian Arthroplasty Register. Arch Orthop Trauma Surg. 2014;134:1361-1368.

9. Zimmerli W, Moser C. Pathogenesis and treatment concepts of orthopaedic biofilm infections. FEMS Immunol Med Microbiol. 2012;65:158-168.